Abstract
Amyloid deposits are formed as a result of uncontrolled aggregation of (poly)peptides or proteins. Today several diseases are known, for example Alzheimer's disease, Creutzfeldt-Jakob disease, mad cow disease, in which amyloid formation is involved. Amyloid fibrils are large aggregates of β-pleated sheets and here a general method is described to introduce molecular mutations in order to achieve disruption of β-sheet formation. Eight backbone-modified amylin derivatives, an amyloidogenic peptide involved in maturity onset diabetes, were synthesized. Their fi-sheet forming properties were studied by IR spectroscopy and electron microscopy. Modification of a crucial amide NH by an alkyl chain led to a complete loss of the β-sheet forming capacity of amylin. The resulting molecular mutated amylin derivative could.be used to break the β-sheet thus retarding β-sheet formation of unmodified amylin. Moreover, it was found that the replacement of this amide bond by an ester moiety suppressed fibrillogenesis significantly. Introduction of N-alkylated amino acids and/or ester functionalities-leading to depsipeptides-into amyloidogenic peptides opens new avenues towards novel peptidic β-sheet breakers for inhibition of β-amyloid aggregation.
| Original language | English |
|---|---|
| Pages (from-to) | 4285-4291 |
| Number of pages | 7 |
| Journal | Chemistry - A European Journal |
| Volume | 8 |
| Issue number | 18 |
| DOIs | |
| Publication status | Published - 16 Sept 2002 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Aggregation
- Amyloid
- Peptides
- Peptidomimetics
- Protein modifications
Fingerprint
Dive into the research topics of 'Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and α-hydroxy acid residue containing peptides'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver